After Concorde.
- 17 April 1993
- Vol. 306 (6884) , 1016-1017
- https://doi.org/10.1136/bmj.306.6884.1016
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Doubt cast on zidovudine's use in delaying AIDS.1993
- NewsBMJ, 1993
- Preliminary analysis of the Concorde trialThe Lancet, 1993
- HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of diseaseNature, 1993
- The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) InfectionAnnals of Internal Medicine, 1990
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- EFFECT OF STAGE OF DISEASE AND DRUG DOSE ON ZIDOVUDINE SUSCEPTIBILITIES OF ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS1990
- ASSOCIATION BETWEEN BIOLOGICAL PROPERTIES OF HUMAN IMMUNODEFICIENCY VIRUS VARIANTS AND RISK FOR AIDS AND AIDS MORTALITYThe Lancet, 1989
- Neuropsychological Outcome of Zidovudine (AZT) Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987